DD trip Anyway hear anything ?, page-6

First 6 Last

Share
Profile

Follow
andres

5,790 Posts.

113

08/06/17

10:31

Post #: 25167831
Share

Originally posted by Tadtech ↑

As a Stratex shareholder I do not feel there is currently enough information out there to make an informed decision on this transaction. Many Stratex shareholders have averages above 3p (some 4p-5p) verses the current 1.4p, for these folk to just get their money back the new entity would need a valuation of £75m-£100m against the current value of Crusader of £25m.

Without the transaction Stratex would only need a valuation of £14m - £20m for that 3p-4p 'target' to be attained, a smaller deal or some form of modest corporate action may be considered a better bet by many holders in a rising gold equity sector.

As a Crusader shareholder I would want to know what level of dilution/debt the new entity will take on to deliver enhanced shareholder value, namely, to bring a project into production. You will get the opportunity of a London listing which should deliver significant volumes of shares traded and hopefully this would drive a re-rate, there are no guarantees. There may also be a share consolidation as 2.4 billion shares in issue is fairly rare on the AIM market these days.

I point out that an all paper offer does not normally deliver the share price uplift in the same way as a cash offer.

Since the transaction announcement the Stratex share price has plummeted to a 12 month low, investors are not happy to say the least.

Marcus Englebrecht was brought into Stratex to bring about change and deliver value but so far he has sold Stratex's main asset, a 45% stake in a newly producing 35k ounces per annum gold mine in Turkey for a derisory $8m and has now decided to dilute the hell out of Stratex's long suffering shareholders by doing a proposed transaction 'priced' near bottom of the Stratex 12 month trading range.

I think the boards of both companies need to deliver to shareholders a clear mission statement on the exact way forward.

These are my personal opinions and no advice is intended.

Expand

Mmm some strength coming into the buy side in harms way at .115 (Chix/ASX).......interesting.

CAS Price at posting: 12.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

There are more pages in this discussion • 4 more messages in this thread...

First 6 Last

Add CAS (ASX) to my watchlist

DD trip Anyway hear anything ?, page-6

Top Stories

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher